Identification of key genes and molecular mechanisms associated with dedifferentiated liposarcoma based on

Hongliang Yu1, Dong Pei2, Longyun Chen2

  • 1Department of Radiation Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing.

Abstract

Insights

Dedifferentiated liposarcoma (DDLPS) is a deadly sarcoma. Bioinformatics analysis revealed significant gene expression differences, identifying key pathways and hub genes like CDK4 and MDM2, advancing understanding of this malignancy.

Area of Science:

  • Oncology
  • Genomics
  • Bioinformatics

Background:

  • Dedifferentiated liposarcoma (DDLPS) is an aggressive soft tissue sarcoma with poorly understood molecular underpinnings.
  • Limited research exists on the molecular mechanisms driving DDLPS, hindering effective therapeutic strategies.

Purpose of the Study:

  • To comprehensively analyze gene expression data from DDLPS samples.
  • To identify differentially expressed genes (DEGs), enriched pathways, and key molecular players in DDLPS.

Main Methods:

  • Utilized Gene Expression Omnibus (GEO) microarray data from 46 DDLPS samples and 9 normal fat controls.
  • Applied hierarchical clustering, principal component analysis, Limma package for DEG identification, DAVID for pathway enrichment, and STRING/Cytoscape for network analysis.
  • Identified hub genes within the protein-protein interaction (PPI) network.

Main Results:

  • Confirmed significant differences in gene expression patterns between DDLPS and normal fat tissues.
  • Identified 700 DEGs, 83 Gene Ontology (GO) terms, and 3 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, including PPAR signaling, cell cycle, and pyruvate metabolism.
  • Constructed a dysregulated PPI network, identified 14 hub genes, and confirmed upregulation and amplification of CDK4 and MDM2.

Conclusions:

  • Bioinformatic analysis of DDLPS microarray data provides deeper insights into its molecular mechanisms.
  • Identified key molecular pathways and genes (CDK4, MDM2) crucial for DDLPS development and progression.
  • This study lays the groundwork for future research into targeted therapies for DDLPS.

Related Concept Videos